Silence Therapeutics Stock Forecast - Relative Strength Index
| SLN Stock | USD 5.67 0.15 2.58% |
Silence Stock outlook is based on your current time horizon. Although Silence Therapeutics' naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Silence Therapeutics' systematic risk associated with finding meaningful patterns of Silence Therapeutics fundamentals over time.
As of today, the RSI of Silence Therapeutics' share price is approaching 43. This usually implies that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Silence Therapeutics, making its price go up or down. Momentum 43
Sell Extended
Oversold | Overbought |
EPS Estimate Next Quarter (0.26) | EPS Estimate Current Year (1.33) | EPS Estimate Next Year (0.90) | Wall Street Target Price 33.8 | EPS Estimate Current Quarter (0.23) |
Using Silence Therapeutics hype-based prediction, you can estimate the value of Silence Therapeutics PLC from the perspective of Silence Therapeutics response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Silence Therapeutics using Silence Therapeutics' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Silence using crowd psychology based on the activity and movement of Silence Therapeutics' stock price.
Silence Therapeutics Implied Volatility | 3.3 |
Silence Therapeutics' implied volatility exposes the market's sentiment of Silence Therapeutics PLC stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Silence Therapeutics' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Silence Therapeutics stock will not fluctuate a lot when Silence Therapeutics' options are near their expiration.
Silence Therapeutics after-hype prediction price | USD 5.57 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Silence Therapeutics to cross-verify your projections. Open Interest Against 2026-04-17 Silence Option Contracts
Although open interest is a measure utilized in the options markets, it could be used to forecast Silence Therapeutics' spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Silence Therapeutics' options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Silence Therapeutics stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Silence Therapeutics' open interest, investors have to compare it to Silence Therapeutics' spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Silence Therapeutics is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Silence. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
Silence Therapeutics Additional Predictive Modules
Most predictive techniques to examine Silence price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Silence using various technical indicators. When you analyze Silence charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Previous Relative Strength Index | Relative Strength Index | Trend |
| 43.59 | 43.59 |
| Check Silence Therapeutics Volatility | Backtest Silence Therapeutics | Information Ratio |
Silence Therapeutics Trading Date Momentum
| On January 26 2026 Silence Therapeutics PLC was traded for 5.67 at the closing time. Highest Silence Therapeutics's price during the trading hours was 6.04 and the lowest price during the day was 5.60 . There was no trading activity during the period 0.0. Lack of trading volume on the 26th of January did not result in any price rise and fall. The trading price change to current price is 2.65% . |
| Compare Silence Therapeutics to competition |
Other Forecasting Options for Silence Therapeutics
For every potential investor in Silence, whether a beginner or expert, Silence Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Silence Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Silence. Basic forecasting techniques help filter out the noise by identifying Silence Therapeutics' price trends.Silence Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Silence Therapeutics stock to make a market-neutral strategy. Peer analysis of Silence Therapeutics could also be used in its relative valuation, which is a method of valuing Silence Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Silence Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Silence Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Silence Therapeutics shares will generate the highest return on investment. By undertsting and applying Silence Therapeutics stock market strength indicators, traders can identify Silence Therapeutics PLC entry and exit signals to maximize returns.
Silence Therapeutics Risk Indicators
The analysis of Silence Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Silence Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting silence stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 2.82 | |||
| Standard Deviation | 3.89 | |||
| Variance | 15.13 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Silence Therapeutics
The number of cover stories for Silence Therapeutics depends on current market conditions and Silence Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Silence Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Silence Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Silence Therapeutics Short Properties
Silence Therapeutics' future price predictability will typically decrease when Silence Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Silence Therapeutics PLC often depends not only on the future outlook of the potential Silence Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Silence Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 15.4 M | |
| Cash And Short Term Investments | 147.3 M |
Check out Historical Fundamental Analysis of Silence Therapeutics to cross-verify your projections. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Silence Therapeutics. If investors know Silence will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Silence Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.35) | Revenue Per Share | Quarterly Revenue Growth (0.89) | Return On Assets | Return On Equity |
The market value of Silence Therapeutics PLC is measured differently than its book value, which is the value of Silence that is recorded on the company's balance sheet. Investors also form their own opinion of Silence Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Silence Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Silence Therapeutics' market value can be influenced by many factors that don't directly affect Silence Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Silence Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Silence Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Silence Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.